@article{c7361d2bf51d4446bdf1e8a97674dd39,
title = "Evidence of epistasis in regions of long-range linkage disequilibrium across five complex diseases in the UK Biobank and eMERGE datasets",
abstract = "Leveraging linkage disequilibrium (LD) patterns as representative of population substructure enables the discovery of additive association signals in genome-wide association studies (GWASs). Standard GWASs are well-powered to interrogate additive models; however, new approaches are required for invesigating other modes of inheritance such as dominance and epistasis. Epistasis, or non-additive interaction between genes, exists across the genome but often goes undetected because of a lack of statistical power. Furthermore, the adoption of LD pruning as customary in standard GWASs excludes detection of sites that are in LD but might underlie the genetic architecture of complex traits. We hypothesize that uncovering long-range interactions between loci with strong LD due to epistatic selection can elucidate genetic mechanisms underlying common diseases. To investigate this hypothesis, we tested for associations between 23 common diseases and 5,625,845 epistatic SNP-SNP pairs (determined by Ohta's D statistics) in long-range LD (>0.25 cM). Across five disease phenotypes, we identified one significant and four near-significant associations that replicated in two large genotype-phenotype datasets (UK Biobank and eMERGE). The genes that were most likely involved in the replicated associations were (1) members of highly conserved gene families with complex roles in multiple pathways, (2) essential genes, and/or (3) genes that were associated in the literature with complex traits that display variable expressivity. These results support the highly pleiotropic and conserved nature of variants in long-range LD under epistatic selection. Our work supports the hypothesis that epistatic interactions regulate diverse clinical mechanisms and might especially be driving factors in conditions with a wide range of phenotypic outcomes.",
keywords = "complex human disease, epistasis, essential genes, evolution, interchromosomal, linkage disequilibrium, long-range, pleiotropy, variable expressivity",
author = "Pankhuri Singhal and Yogasudha Veturi and Dudek, {Scott M.} and Anastasia Lucas and Alex Frase and {van Steen}, Kristel and Schrodi, {Steven J.} and David Fasel and Chunhua Weng and Rion Pendergrass and Schaid, {Daniel J} and Kullo, {Iftikhar J.} and Ozan Dikilitas and Sleiman, {Patrick M.A.} and Hakon Hakonarson and Moore, {Jason H.} and Williams, {Scott M.} and Ritchie, {Marylyn D.} and Verma, {Shefali S.}",
note = "Funding Information: The authors would like to acknowledge their funding sources. M.D.R. is supported by R01 HG010067 and U01 AG066833. J.H.M. is supported by R01 LM010098 and U01 AG066833. P.S. is supported by F31 AG069441-01. eMERGE Network (phase III): This phase of the eMERGE Network was initiated and funded by the NHGRI through the following grants: U01HG8657 (Group Health Cooperative/University of Washington); U01HG8685 (Brigham and Women's Hospital); U01HG8672 (Vanderbilt University Medical Center); U01HG8666 (Cincinnati Children's Hospital Medical Center); U01HG6379 (Mayo Clinic); U01HG8679 (Geisinger Clinic); U01HG8680 (Columbia University Health Sciences); U01HG8684 (Children's Hospital of Philadelphia); U01HG8673 (Northwestern University); U01HG8701 (Vanderbilt University Medical Center, serving as the coordinating center); U01HG8676 (Mass General Brigham and Broad Institute); and U01HG8664 (Baylor College of Medicine). The authors would also like to thank Stephen Schaeffer and the participants of the Epistasis Discovery in Genetics and Epidemiology (EDGE) meeting over the years for their insightful discussion and feedback that has guided this project. The authors declare no competing interests. Funding Information: The authors would like to acknowledge their funding sources. M.D.R . is supported by R01 HG010067 and U01 AG066833 . J.H.M . is supported by R01 LM010098 and U01 AG066833 . P.S . is supported by F31 AG069441-01 . eMERGE Network (phase III): This phase of the eMERGE Network was initiated and funded by the NHGRI through the following grants: U01HG8657 (Group Health Cooperative/ University of Washington ); U01HG8685 ( Brigham and Women's Hospital ); U01HG8672 ( Vanderbilt University Medical Center ); U01HG8666 ( Cincinnati Children's Hospital Medical Center ); U01HG6379 ( Mayo Clinic ); U01HG8679 ( Geisinger Clinic ); U01HG8680 ( Columbia University Health Sciences ); U01HG8684 ( Children's Hospital of Philadelphia ); U01HG8673 ( Northwestern University ); U01HG8701 ( Vanderbilt University Medical Center , serving as the coordinating center); U01HG8676 ( Mass General Brigham and Broad Institute ); and U01HG8664 ( Baylor College of Medicine ). The authors would also like to thank Stephen Schaeffer and the participants of the Epistasis Discovery in Genetics and Epidemiology (EDGE) meeting over the years for their insightful discussion and feedback that has guided this project. Publisher Copyright: {\textcopyright} 2023 American Society of Human Genetics",
year = "2023",
month = apr,
day = "6",
doi = "10.1016/j.ajhg.2023.03.007",
language = "English (US)",
volume = "110",
pages = "575--591",
journal = "American Journal of Human Genetics",
issn = "0002-9297",
publisher = "Cell Press",
number = "4",
}